Trial record 1 of 2 for:    CB-839 lung
Previous Study | Return to List | Next Study

Study CB-839 in Combination With Nivolumab in Patients With Melanoma, ccRCC and NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02771626
Recruitment Status : Recruiting
First Posted : May 13, 2016
Last Update Posted : May 18, 2018
Information provided by (Responsible Party):
Calithera Biosciences, Inc

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : June 2019